Merit Medical Sys (MMSI) 20.68 $MMSI
Merit Medical to Present at UBS Global Healthcare Conference
GlobeNewswire - Thu May 12, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global Healthcare Conference being held May 23-25 at the Grand Hyatt New York.
MMSI: 20.68 (-0.21)
Merit Medical Appointed Global Distributor for Micro Guide Wire
GlobeNewswire - Tue May 10, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has signed a distribution deal with PIOLAX Medical Devices, Inc. of Yokohama, Japan for a product known in Japan as the Labyrinth Noah(TM) Micro Guide Wire. The deal covers all global markets, with the exception of Japan, and is subject to certain minimum order requirements.
MMSI: 20.68 (-0.21)
Merit Medical meets 1Q profit forecasts
Automated Insights - Thu Apr 28, 6:44PM CDT
SOUTH JORDAN, Utah (AP) _ Merit Medical Systems Inc. (MMSI) on Thursday reported first-quarter profit of $4.4 million.
MMSI: 20.68 (-0.21)
Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
GlobeNewswire - Thu Apr 28, 3:00PM CDT
-- Q1 revenue of $138.1 million ($140.0 million in constant currency), up 6.6% as reported, up 8.0% on a comparable, constant currency basis
MMSI: 20.68 (-0.21)
Merit Medical Systems to Announce First Quarter Results on April 28, 2016
GlobeNewswire - Mon Apr 04, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2016, after the close of the stock market on Thursday, April 28, 2016.
MMSI: 20.68 (-0.21)
Merit Medical Announces 510(k) Clearance for Corvocet(TM) Biopsy System
GlobeNewswire - Mon Mar 28, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it received notification of substantial equivalence from the FDA for the Corvocet(TM) Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumors.
MMSI: 20.68 (-0.21)
Merit Medical to Present at Four Conferences
GlobeNewswire - Wed Feb 10, 8:30AM CST
RBC Capital Markets - February 24
MMSI: 20.68 (-0.21)
Global Non-vascular Stents Market 2016-2020 with Boston Scientific, Cook Medical, C.R. Bard & Medtronic Dominating
M2 - Mon Feb 08, 11:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/lhzzfb/global) has announced the addition of the "Global Non-vascular Stents Market 2016-2020" report to their offering. The global non-vascular stents market to grow at a CAGR of 5.24% during the period 2016-2020. Global Non-vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Advances in technology have resulted in the introduction of stents in a wide range of sizes, designs, and materials. A typical gastrointestinal or urologic stent is about 18 cm. There are other micro stents available for different stent applications. The use of biodegradable polymer in non-vascular stents has the advantages of biocompatibility and eliminating the need for stent removal. According to the report, the increased incidence of gastrointestinal disorders such as colon cancer, rectal cancer, and other urological conditions, coupled with the aging population, is driving market growth. Further, the report states that complications associated with non-vascular stents restricts the market growth. To calculate the market size, the report considers the revenue generated from the sales of non-vascular stents, which are segmented as follows: - Gastrointestinal stents - Urological stents - Pulmonary stents Key vendors - Boston Scientific - Cook Medical - C.R. Bard - Medtronic Other prominent vendors - Allium Medical - EFER Endoscopy - Amecath - Applied Medical - BIOTEQ - BVM Medical - Coloplast - ConMed - ELLA-CS - EndoChoice - Hobbs Medical - Merit Endotek - Merit Medical Systems - Novatech - Olympus - Surgimedik - Taewoong Medical - Xlumena For more information visit http://www.researchandmarkets.com/research/lhzzfb/global
BSX: 23.77 (-0.13), MDT: 88.51 (+0.15), MMSI: 20.68 (-0.21)
Merit Medical Systems Down 21.8% Since SmarTrend Downtrend Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 05, 6:07PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 21.75% as of today's recent price of $15.72.
MMSI: 20.68 (-0.21)
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 22, 2016
GlobeNewswire - Thu Feb 04, 3:00PM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the fourth quarter and year ended December 31, 2015, after the close of the stock market on Monday, February 22, 2016.
MMSI: 20.68 (-0.21)
Merit Medical Acquires the HeRO(R)Graft From CryoLife, Inc.
GlobeNewswire - Thu Feb 04, 10:04AM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has purchased the HeRO(R)Graft device and related assets from CryoLife, Inc.
CRY: 12.19 (-0.04), MMSI: 20.68 (-0.21)
CryoLife Announces Sale of HeRO Graft to Merit Medical Systems
PR Newswire - Thu Feb 04, 7:04AM CST
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it sold its HeRO Graft product line to Merit Medical Systems, Inc. (NASDAQ: MMSI) for $18.5 million in cash.
CRY: 12.19 (-0.04), MMSI: 20.68 (-0.21)
Merit Medical Systems Shares Down 18.3% Since SmarTrend's Sell Call (MMSI)
Comtex SmarTrend(R) - Fri Jan 29, 5:27PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 3 months, Merit Medical Systems has returned 18.27% as of today's recent price of $16.42.
MMSI: 20.68 (-0.21)
Catheter Stabilization Device/Catheter Securement Devices Market (2015-2020) - Increasing Healthcare Expenditure Driving Growth
M2 - Thu Jan 28, 5:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkxh94/catheter) has announced the addition of the "Catheter Stabilization Device/Catheter Securement Devices Market - Global Forecast to 2020" report to their offering. The global catheter stabilization device market is expected to reach $1,372.35 Million by 2020 from $957.26 Million in 2015, growing at a CAGR of 7.47% between 2015 and 2020. Increasing healthcare expenditures and demand for minimal invasive surgeries will drive the growth of the securement devices market. This report segments the global catheter stabilization device market by products, applications and end users. The global market product segments included in the report comprises of arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global securement devices market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the increasing healthcare expenditure and aging population from this region. Companies Mentioned: - 3M Company - B. Braun Melsungen Ag - Baxter International, Inc. - C. R. Bard, Inc. - Centurion Medical Products - Convatec, Inc. - M. C. Johnson Company, Inc. - Medtronic PLC - Merit Medical Systems, Inc. - Smiths Group PLC Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Catheter Stabilization Device Market, By Product 7 Catheter Stabilization Device Market, By End User 8 Catheter Stabilization Device Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/hkxh94/catheter
MMM: 178.01 (+0.89), MDT: 88.51 (+0.15), BAX: 46.49 (-0.16), MMSI: 20.68 (-0.21)
US Market for Peripheral Vascular Devices and Accessories Report Suite 2016
M2 - Fri Jan 15, 4:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/l5kqqx/us_market_for) has announced the addition of the "US Market for Peripheral Vascular Devices and Accessories Report Suite - 2016" report to their offering. Growth in the value of the U.S. market for peripheral vascular devices is being driven by the aging U.S. population, improving public awareness of peripheral arterial disease (PAD) and improvements in medical device technology. The transcatheter embolization device market is expected to be the fastest growing segment, increasing at a CAGR in the mid-to-high teens over the forecast period. The strong growth in this market will be a result of the increase in usage of radiolabeled and drug-eluting beads as well as the increasing penetration rate of detachable embolization coils. The U.S. market for peripheral vascular devices includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent grafts, surgical grafts, thrombectomy devices, inferior vena cava filters (IVCFs), catheters, guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices. Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report. Key Topics Covered: 1 Overview 2 Research Methodology 3 U.S. Peripheral Vascular Device Market Overview 4 Procedure Numbers 5 Peripheral Vascular Stent Market 6 PTA Balloon Catheter Market 7 Atherectomy Device Market 8 Chronic Total Occlusion Device Market 9 Embolic Protection Device Market 10 Stent Graft Market 11 Surgical Graft Market 12 Thrombectomy Device Market 13 Inferior Vena Cava Filter Market 14 Diagnostic And Interventional Catheter Market 15 Diagnostic And Interventional Guidewire Market 16 Introducer Sheath Market Companies Mentioned - Medtronic - W.L. Gore - Cook Medical - Boston Scientific - C.R. Bard - Abbott Laboratories - Cardinal Health - Terumo - Endologix - Cardiovascular Systems Inc. - Sirtex - Maquet - BTG - St. Jude Medical - Spectranetics - Teleflex Medical - Advanced Vascular Dynamics - AngioSlide - Arstasis - C.R. Bard - Creagh Medical - EndoShape - HemCon Medical Technologies - Merit Medical Systems, Inc. - Morris Innovative, Inc. - Nantec Medical - Penumbra - Pfizer - Silk Road Medical - Teleflex Medical - Terumo - TriReme Medical - TZ Medical - Vascular Flow Technologies - W.L. Gore For more information visit http://www.researchandmarkets.com/research/l5...market_for
BSX: 23.77 (-0.13), SPNC: 20.36 (+0.12), ABT: 42.12 (+0.23), MDT: 88.51 (+0.15), CSII: 19.32 (-0.30), STJ: 80.67 (+0.09), MMSI: 20.68 (-0.21)
Downtrend Call Working As Merit Medical Systems Stock Falls 20.9% (MMSI)
Comtex SmarTrend(R) - Thu Jan 14, 4:15PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 3 months, Merit Medical Systems has returned 20.86% as of today's recent price of $15.90.
MMSI: 20.68 (-0.21)
Merit Medical to Present at UBS Global Healthcare Conference
GlobeNewswire - Thu May 12, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global Healthcare Conference being held May 23-25 at the Grand Hyatt New York.
MMSI: 20.68 (-0.21)
Merit Medical Appointed Global Distributor for Micro Guide Wire
GlobeNewswire - Tue May 10, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has signed a distribution deal with PIOLAX Medical Devices, Inc. of Yokohama, Japan for a product known in Japan as the Labyrinth Noah(TM) Micro Guide Wire. The deal covers all global markets, with the exception of Japan, and is subject to certain minimum order requirements.
MMSI: 20.68 (-0.21)
Merit Medical meets 1Q profit forecasts
Automated Insights - Thu Apr 28, 6:44PM CDT
SOUTH JORDAN, Utah (AP) _ Merit Medical Systems Inc. (MMSI) on Thursday reported first-quarter profit of $4.4 million.
MMSI: 20.68 (-0.21)
Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
GlobeNewswire - Thu Apr 28, 3:00PM CDT
-- Q1 revenue of $138.1 million ($140.0 million in constant currency), up 6.6% as reported, up 8.0% on a comparable, constant currency basis
MMSI: 20.68 (-0.21)
Merit Medical Systems to Announce First Quarter Results on April 28, 2016
GlobeNewswire - Mon Apr 04, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2016, after the close of the stock market on Thursday, April 28, 2016.
MMSI: 20.68 (-0.21)
Merit Medical Announces 510(k) Clearance for Corvocet(TM) Biopsy System
GlobeNewswire - Mon Mar 28, 8:30AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it received notification of substantial equivalence from the FDA for the Corvocet(TM) Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumors.
MMSI: 20.68 (-0.21)
Merit Medical to Present at Four Conferences
GlobeNewswire - Wed Feb 10, 8:30AM CST
RBC Capital Markets - February 24
MMSI: 20.68 (-0.21)
Global Non-vascular Stents Market 2016-2020 with Boston Scientific, Cook Medical, C.R. Bard & Medtronic Dominating
M2 - Mon Feb 08, 11:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/lhzzfb/global) has announced the addition of the "Global Non-vascular Stents Market 2016-2020" report to their offering. The global non-vascular stents market to grow at a CAGR of 5.24% during the period 2016-2020. Global Non-vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Advances in technology have resulted in the introduction of stents in a wide range of sizes, designs, and materials. A typical gastrointestinal or urologic stent is about 18 cm. There are other micro stents available for different stent applications. The use of biodegradable polymer in non-vascular stents has the advantages of biocompatibility and eliminating the need for stent removal. According to the report, the increased incidence of gastrointestinal disorders such as colon cancer, rectal cancer, and other urological conditions, coupled with the aging population, is driving market growth. Further, the report states that complications associated with non-vascular stents restricts the market growth. To calculate the market size, the report considers the revenue generated from the sales of non-vascular stents, which are segmented as follows: - Gastrointestinal stents - Urological stents - Pulmonary stents Key vendors - Boston Scientific - Cook Medical - C.R. Bard - Medtronic Other prominent vendors - Allium Medical - EFER Endoscopy - Amecath - Applied Medical - BIOTEQ - BVM Medical - Coloplast - ConMed - ELLA-CS - EndoChoice - Hobbs Medical - Merit Endotek - Merit Medical Systems - Novatech - Olympus - Surgimedik - Taewoong Medical - Xlumena For more information visit http://www.researchandmarkets.com/research/lhzzfb/global
BSX: 23.77 (-0.13), MDT: 88.51 (+0.15), MMSI: 20.68 (-0.21)
Merit Medical Systems Down 21.8% Since SmarTrend Downtrend Call (MMSI)
Comtex SmarTrend(R) - Fri Feb 05, 6:07PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 4 months, Merit Medical Systems has returned 21.75% as of today's recent price of $15.72.
MMSI: 20.68 (-0.21)
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 22, 2016
GlobeNewswire - Thu Feb 04, 3:00PM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the fourth quarter and year ended December 31, 2015, after the close of the stock market on Monday, February 22, 2016.
MMSI: 20.68 (-0.21)
Merit Medical Acquires the HeRO(R)Graft From CryoLife, Inc.
GlobeNewswire - Thu Feb 04, 10:04AM CST
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has purchased the HeRO(R)Graft device and related assets from CryoLife, Inc.
CRY: 12.19 (-0.04), MMSI: 20.68 (-0.21)
CryoLife Announces Sale of HeRO Graft to Merit Medical Systems
PR Newswire - Thu Feb 04, 7:04AM CST
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it sold its HeRO Graft product line to Merit Medical Systems, Inc. (NASDAQ: MMSI) for $18.5 million in cash.
CRY: 12.19 (-0.04), MMSI: 20.68 (-0.21)
Merit Medical Systems Shares Down 18.3% Since SmarTrend's Sell Call (MMSI)
Comtex SmarTrend(R) - Fri Jan 29, 5:27PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 3 months, Merit Medical Systems has returned 18.27% as of today's recent price of $16.42.
MMSI: 20.68 (-0.21)
Catheter Stabilization Device/Catheter Securement Devices Market (2015-2020) - Increasing Healthcare Expenditure Driving Growth
M2 - Thu Jan 28, 5:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkxh94/catheter) has announced the addition of the "Catheter Stabilization Device/Catheter Securement Devices Market - Global Forecast to 2020" report to their offering. The global catheter stabilization device market is expected to reach $1,372.35 Million by 2020 from $957.26 Million in 2015, growing at a CAGR of 7.47% between 2015 and 2020. Increasing healthcare expenditures and demand for minimal invasive surgeries will drive the growth of the securement devices market. This report segments the global catheter stabilization device market by products, applications and end users. The global market product segments included in the report comprises of arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global securement devices market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the increasing healthcare expenditure and aging population from this region. Companies Mentioned: - 3M Company - B. Braun Melsungen Ag - Baxter International, Inc. - C. R. Bard, Inc. - Centurion Medical Products - Convatec, Inc. - M. C. Johnson Company, Inc. - Medtronic PLC - Merit Medical Systems, Inc. - Smiths Group PLC Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Catheter Stabilization Device Market, By Product 7 Catheter Stabilization Device Market, By End User 8 Catheter Stabilization Device Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/hkxh94/catheter
MMM: 178.01 (+0.89), MDT: 88.51 (+0.15), BAX: 46.49 (-0.16), MMSI: 20.68 (-0.21)
US Market for Peripheral Vascular Devices and Accessories Report Suite 2016
M2 - Fri Jan 15, 4:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/l5kqqx/us_market_for) has announced the addition of the "US Market for Peripheral Vascular Devices and Accessories Report Suite - 2016" report to their offering. Growth in the value of the U.S. market for peripheral vascular devices is being driven by the aging U.S. population, improving public awareness of peripheral arterial disease (PAD) and improvements in medical device technology. The transcatheter embolization device market is expected to be the fastest growing segment, increasing at a CAGR in the mid-to-high teens over the forecast period. The strong growth in this market will be a result of the increase in usage of radiolabeled and drug-eluting beads as well as the increasing penetration rate of detachable embolization coils. The U.S. market for peripheral vascular devices includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent grafts, surgical grafts, thrombectomy devices, inferior vena cava filters (IVCFs), catheters, guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices. Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report. Key Topics Covered: 1 Overview 2 Research Methodology 3 U.S. Peripheral Vascular Device Market Overview 4 Procedure Numbers 5 Peripheral Vascular Stent Market 6 PTA Balloon Catheter Market 7 Atherectomy Device Market 8 Chronic Total Occlusion Device Market 9 Embolic Protection Device Market 10 Stent Graft Market 11 Surgical Graft Market 12 Thrombectomy Device Market 13 Inferior Vena Cava Filter Market 14 Diagnostic And Interventional Catheter Market 15 Diagnostic And Interventional Guidewire Market 16 Introducer Sheath Market Companies Mentioned - Medtronic - W.L. Gore - Cook Medical - Boston Scientific - C.R. Bard - Abbott Laboratories - Cardinal Health - Terumo - Endologix - Cardiovascular Systems Inc. - Sirtex - Maquet - BTG - St. Jude Medical - Spectranetics - Teleflex Medical - Advanced Vascular Dynamics - AngioSlide - Arstasis - C.R. Bard - Creagh Medical - EndoShape - HemCon Medical Technologies - Merit Medical Systems, Inc. - Morris Innovative, Inc. - Nantec Medical - Penumbra - Pfizer - Silk Road Medical - Teleflex Medical - Terumo - TriReme Medical - TZ Medical - Vascular Flow Technologies - W.L. Gore For more information visit http://www.researchandmarkets.com/research/l5...market_for
BSX: 23.77 (-0.13), SPNC: 20.36 (+0.12), ABT: 42.12 (+0.23), MDT: 88.51 (+0.15), CSII: 19.32 (-0.30), STJ: 80.67 (+0.09), MMSI: 20.68 (-0.21)
Downtrend Call Working As Merit Medical Systems Stock Falls 20.9% (MMSI)
Comtex SmarTrend(R) - Thu Jan 14, 4:15PM CST
SmarTrend identified a Downtrend for Merit Medical Systems (NASDAQ:MMSI) on October 23rd, 2015 at $20.09. In approximately 3 months, Merit Medical Systems has returned 20.86% as of today's recent price of $15.90.
MMSI: 20.68 (-0.21)
